Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Burzynski Clinic Presents Over Five Years Survival Data From Phase II Trials of ANP for Inoperable Brain Tumors at the Congress

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/16/2013 | 03:34am CEST

The Burzynski Clinic (BC) announced today that it made a keynote speaker presentation at the 2nd Annual Congress of Asia-Pacific Academy of Anti-Aging Medicine in Beijing, China. Based on the presentation in Beijing, a total of 401 eligible patients (patients who received over 28 days of treatment) with advanced inoperable brain tumors have been treated with antineoplaston A10 and antineoplastons AS2-1 therapy (ANP) in phase II studies. Most of the patients (87%) were diagnosed with high-grade tumors and the remaining patients were diagnosed with low-grade tumors. The patients were diagnosed by pathologists not associated with BC and objective responses were verified by Central Radiology Review. The group of 77 patients (19%) survived over five years from the treatment start. Of particular interest were results in patients with brainstem gliomas. The group of 17 patients with brainstem glioma underwent the treatment and 65% of these patients survived over five years. An additional group of 42 patients diagnosed with diffuse intrinsic pontine glioma (DIPG) have been treated and a total of 19% survived over five years.

The quality of survival is very good and there is no long-term toxicity related to ANP.

These clinical results are very encouraging, since they describe a positive ANP effect on some of the worst malignancies in the entire oncology field, but they will require FDA approval.

Burzynski Clinic is committed to developing treatments for cancer based on genomic and epigenomic principles.

Forward-looking statements in this release are made pursuant to the safe harbor provisions of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change, and future events may differ materially from those discussed herein due to a number of factors, including, but not limited to, risks and uncertainties related to the clinic's ability to use Antineoplastons A10 and AS2-1. Burzynski Clinic does not undertake to update any such forward-looking statements or to publicly announce developments or events relating to the matters described herein.

For Burzynski Clinic
Carolyn Powers, 713-335-5664
[email protected]


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
12:35a CELSIUS RESOURCES : Quarterly Cashflow Report
12:35a CELSIUS RESOURCES : Quarterly Activities Report
12:20a ALARA RESOURCES : Quarterly Activities and Cashflow Reports
12:15a MUSTANG RESOURCES : Quarterly Report & Appendix 5B
12:15a FIJI SUGAR : Appointment of Chief Financial Officer (CFO)
12:15a COCHLEAR : Change in substantial holding
04/30 SPORTING C D PORTUGAL : Sp. Braga, 2-Sporting CP, 3
04/30 Lake Ontario shoreline property owners watch property wash away
04/30 MERIDIAN ENERGY : commits to converting 50% of its fleet to electric vehicles by June 2018
04/30 GENESIS ENERGY : Q3 2017 Performance Report
Latest news
Advertisement
Hot News 
5.97%REGENERON PHARMACEUTICALS : Sanofi beats profit forecasts, upbeat on prospects for eczema drug
5.37%AIR BERLIN : Restructuring costs drive Air Berlin to record loss
3.71%Google parent Alphabet's profit up 29 percent on strong ad sales
-3.42%INTEL : revenue misses estimates as data centre growth slows
-4.06%Baidu's Finance Chief to Lead Investment Firm Baidu Capital -- Update
Most Read News
06:15p COCHLEAR : Change in substantial holding
06:15p MUSTANG RESOURCES : Quarterly Report & Appendix 5B
06:20p ALARA RESOURCES : Quarterly Activities and Cashflow Reports
06:35p CELSIUS RESOURCES : Quarterly Activities Report
01:05p Off target in 2016, global elite regroup at Milken conference
Most recommended articles
04/27 JPMorgan Chase & Co leaves blockchain consortium R3
04:10pDJAPPLE : Cash Hoard Set to Top $250 Billion
03:48pDJDetroit Auto Makers Are Upbeat as Sales Volumes Stall
02:47p UNITED PARCEL SERVICE : UPS air maintenance workers threaten strike ahead of shareholders meeting
02:41pDJMACY : Bluemercury to Open Manhattan Flagship Store